Evaluation of Recent-Onset Forgetfulness in Adults with Family History of Alzheimer's Disease
Introduction to Diagnostic Approach
- The American Academy of Neurology recommends a comprehensive cognitive evaluation, including detailed history from an informant, objective cognitive testing, basic laboratory workup, and brain MRI to determine the etiology of symptoms in patients with recent-onset forgetfulness and a family history of Alzheimer's disease 1, 2
Importance of Age and Family History
- The American College of Medical Genetics and Genomics notes that early-onset Alzheimer's disease (EOAD) accounts for 1-5% of all AD cases and typically presents before age 60-65 years, making age and family history critical red flags 3
- A family history of Alzheimer's disease at least doubles the lifetime risk from the general population baseline of 10-12% 4
History Taking and Cognitive Assessment
- Obtain history from both the patient and a knowledgeable informant separately, as patients with cognitive impairment often have diminished insight into their condition, as recommended by the American Academy of Neurology 1, 5
- Assess other cognitive domains beyond memory, including word-finding difficulties, language problems, difficulty with complex tasks, problems with attention, concentration, or multitasking, and geographic disorientation or visuospatial difficulties 5
- Screen for functional impact on instrumental activities of daily living, such as managing finances, medication management, driving ability, using electronics or technology, and work performance changes 1, 5
Objective Cognitive Testing and Laboratory Workup
- Administer a validated cognitive screening tool, such as the Montreal Cognitive Assessment (MoCA), immediately to detect mild cognitive impairment, as recommended by the Journal of Internal Medicine 2, 6
- Order baseline tests to exclude reversible causes and assess vascular risk factors, including complete blood count with differential, complete metabolic panel, thyroid-stimulating hormone (TSH), vitamin B12 and homocysteine, lipid panel, and HbA1c 2, 6
Neuroimaging and Genetic Counseling
- Obtain brain MRI (or head CT if MRI contraindicated) to assess for structural abnormalities, vascular disease, mass lesions, or patterns of atrophy, as recommended by the Journal of Internal Medicine 2
- Refer to a genetic counselor for discussion of genetic testing for EOAD genes (PSEN1, PSEN2, APP) if there is evidence of autosomal dominant inheritance, as recommended by the American College of Medical Genetics and Genomics 3, 7
Follow-Up Strategy and Specialty Referral
- Schedule follow-up assessment in 6 months using the same cognitive instrument to determine if the patient is declining, stable, or improving, as recommended by the Journal of Internal Medicine 2
- Refer to neurology, geriatric psychiatry, or a memory disorders specialist if cognitive testing confirms impairment, diagnosis remains unclear, or patient or family requests discussion of genetic testing, as recommended by the Journal of Internal Medicine 2, 7